Cow superovulation sustained-release agent and preparation method thereof
A slow-release agent and hyaluronic acid technology, which is applied in the direction of pharmaceutical formulations, medical preparations with non-active ingredients, medical preparations containing active ingredients, etc., can solve the problems affecting the efficiency of superovulation of cattle and the stress of donor cattle. Response is large, the labor cost of cattle farms increases, etc., to achieve the effect of easy operation and popularization, prolonging the action time, and improving the efficiency of super-expelling
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0014] Preparation of 10.0 mg / mL sustained-release agent: Weigh 100.0 mg of hyaluronic acid with an electronic balance, and dissolve 100.0 mg of hyaluronic acid in 10.0 mL of deionized water according to the concentration standard of 10.0 mg / mL. Save the settings.
[0015] Dilution of FSH: FSH is fully dissolved and diluted with 20.0mL water for injection.
[0016] Preparation of FSH-sustained release agent:
[0017] Step 1: Pre-dilution of FSH: use a 2.0mL syringe to draw 1.0mL water for injection to dilute 400.0mg of FSH, and let it stand for use after fully dissolved;
[0018] Step 2: FSH-sustained-release agent mixing: Use a 10.0mL syringe to draw 9.0mL superexhaust sustained-release agent solution, mix it with 1.0mL FSH solution to prepare 10.0ml FSH-sustained-release agent solution, and mix thoroughly in a 40°C water bath Evenly, set aside.
experiment example 1
[0020] 1. Donor cows: 15 adult dairy cows aged 40-45 months and weighing 500-550kg were selected as donors.
[0021] 2. Superovulation treatment of donor cattle
[0022] 2.1 Conventional superovulation treatment (FSH group): implant vaginal suppository (CIDR) on any day of the estrus cycle of the donor cattle (except the day of estrus) (day 0), intramuscularly inject 4.0 mL of FSH in the morning and evening of day 5; Intramuscular injection of 3mL FSH in the morning and evening of the 7th day; 2.0mL FSH in the morning and evening of the 7th day; 1.0mL FSH in the morning and evening of the 8th day. On the 7th day, FSH was injected and cloprostenol 0.6 mg and 0.4 mg were injected intramuscularly (3 and 2 tubes), respectively, and the vaginal suppository was removed on the evening of the 7th day (Table 1).
[0023] 2.2 Superovulation treatment with slow-release agent (FSH-SRF group): implant vaginal suppository (CIDR) on any day of the estrus cycle of the donor cow (except the d...
experiment example 2
[0034] 1. Donor cows: select 2 adult cows that have been used for conventional superovulation as donors
[0035] 2. The specific steps are the same as 2.2 in Experimental Example 1
[0036] 3. Results: 24 embryos were obtained from 2 donor cows, and the number of usable embryos was 7.0 per head.
[0037] The above experimental examples show that hyaluronic acid is added to FSH as a slow-release agent, which delays the release of exogenous FSH in the donor cattle, can obtain a superovulation effect equivalent to the conventional superovulation effect, and simplifies the superovulation procedure of cattle .
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com